Aman Chauhan: Latest ASCO guidelines on functional Neuroendocrine Tumors (NETs)
Aman Chauhan, Leader of Neuroendocrine Cancer Program at Sylvester Comprehensive Cancer Center, shared a post by Mark Lewis, Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, on X, adding:
“Check out the latest ASCO guidelines on functional NETs. While management of well-differentiated NETs is often nuanced, three critical factors should be assessed at the initial visit to guide an effective treatment plan:
1. Tumor Grade
2. Disease Stage
3. Functional Status.”
Quoting Mark Lewis‘s post:
“Well-differentiated neuroendocrine tumors are not just “cancer-like”! Frequently misnomered they can be profoundly detrimental to both longevity and quality of life New ASCO guidance on symptom management in NETs”
Title: Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
Journal: JCO Oncology Practice
Authors: Kimberly Perez, Jaydira Del Rivero, Erin B. Kennedy, Sandip Basu, Aman Chauhan, Heidi M. Connolly, Arvind N. Dasari, Alexandra Gangi, Callisia N. Clarke, Julie Hallet, James R. Howe, Erin Grady, Jana Ivanidze, Erik S. Mittra, Sarah B. White, Nitya P. Raj, Namrata Vijayvergia, Mark A. Lewis, Jennifer A. Chan, Pamela L. Kunz, Josh Mailman, Junaid Arshad, Heloisa P. Soares, Simron Singh, Chandrika Chandrasekharan, Michael C. Soulen, Eva Tiensuu Janson, Thorvardur R. Halfdanarson, Jonathan R. Strosberg, Emily K. Bergsland
Read Full Article on ASCO Publications.
More posts featuring Aman Chauhan and Mark Lewis on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023